Arterial hypertension and cognitive disorders. Mexidol's effectiveness

Time codes:
  • 02:30

    Portrait of a patient with arterial hypertension

  • 05:24

    The brain is an organ of the target of arterial hypertension. 

  • 06:00

    Approach to early diagnosis of patients 

  • 08:00

    Montreal scale for evaluating cognitive functions (Mosa –Test)

  • 09:08

    Digital symbol replacement test 

  • 09:40

    Trail Making Test (TMT)

  • 11:10

    Target levels of blood pressure 

  • 12:15

    Antihypertensive drugs and related risk factors

  • 14:10

    Features of neuroprotectors for patients with arterial hypertension

  • 19:14

    Mexidol® is an effective neuroprotector with evidence

  • 19:50

    Long -term and consistent therapy with Mexidol® in a memo study  

Evgeniya Viktorovna Yekusheva – Doctor of Medical Sciences, Professor, Head of the Department of Nervous System Diseases and Neurorehabilitation of the Academy of Postgraduate Education of the Federal Scientific and Clinical Center of the Federal Medical and Biological Agency of Russia

Aleksey Ivanovich Kochetkov, PhD, Associate Professor, Department of Therapy and Polymorbid Pathology named after Academician M.S. Vovsi, Federal State Budgetary Educational Institution of Higher Professional Education, Russian Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation

Announcement:

The brain is one of the main target organs of arterial hypertension. The most common cerebral symptoms of arterial hypertension should include headaches mainly in the nape area, as a rule, in the morning, dizziness of varying degrees of severity, noise in the ears and visual impairment. Mexidol® is a drug that has an evidence base and is effective for patients with arterial hypertension.

Time codes:
  • 02:30

    Portrait of a patient with arterial hypertension

  • 05:24

    The brain is an organ of the target of arterial hypertension. 

  • 06:00

    Approach to early diagnosis of patients 

  • 08:00

    Montreal scale for evaluating cognitive functions (Mosa –Test)

  • 09:08

    Digital symbol replacement test 

  • 09:40

    Trail Making Test (TMT)

  • 11:10

    Target levels of blood pressure 

  • 12:15

    Antihypertensive drugs and related risk factors

  • 14:10

    Features of neuroprotectors for patients with arterial hypertension

  • 19:14

    Mexidol® is an effective neuroprotector with evidence

  • 19:50

    Long -term and consistent therapy with Mexidol® in a memo study  

Block of articles on this topic

Resolution of the Council of Experts "The possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders"

Presidium of the Council of Experts:

Martynov A.I., Doctor of Medical Sciences, Professor, Academician of the Russian Academy of Sciences, Professor of the Department of Hospital Therapy No. 1 of the A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation, President of the Russian Scientific Medical Society of Therapists (RSMST), Moscow

Tanashyan M.M., Doctor of Medical Sciences, Professor, Corresponding Member of the Russian Academy of Sciences, Deputy Director for Research, Federal State Budgetary Scientific Institution "Scientific Center of Neurology", Moscow

Malyavin A.G., Doctor of Medical Sciences, Professor of the Department of Phthisiology and Pulmonology of the Faculty of Medicine of the Federal State Budgetary Educational Institution of Higher Education “Moscow State University of Medicine and Dentistry named after A.I. Evdokimov” of the Ministry of Health of the Russian Federation, Chief Pulmonologist of the Ministry of Health of the Russian Federation for the Central Federal District, Secretary General of the Russian Scientific and Practical Society of the Russian Federation, Moscow

Participants in the Council of Experts:

Bogolepova A.N., Doctor of Medical Sciences, Head of the Department of Cognitive Impairments, Federal Center for Brain and Neurotechnology, Federal Medical and Biological Agency of Russia; Professor, Department of Neurology, Neurosurgery, and Medical Genetics, Faculty of Medicine, N.I. Pirogov Russian National Research Medical University, Moscow

Borovkova N.Yu., Doctor of Medical Sciences, First Deputy Director of the Institute of Therapy, Professor of the Department of Hospital Therapy and General Medical Practice, Federal State Budgetary Educational Institution of Higher Education “Volga Region Research Medical University” of the Ministry of Health of the Russian Federation, Nizhny Novgorod

Eliseeva L.N., Doctor of Medical Sciences, Professor, Head of the Department of Faculty Therapy, Federal State Budgetary Educational Institution of Higher Education “Kuban State Medical University” of the Ministry of Health of the Russian Federation, Chairman of the Krasnodar Regional Branch of the Russian National Medical and Orthopaedic Society, Krasnodar

Zhuravleva M.V., Doctor of Medical Sciences, Professor, Professor of the Department of Clinical Pharmacology and Propaedeutics of Internal Diseases of the Federal State Autonomous Educational Institution of Higher Education “First Moscow State Medical University named after I.M. Sechenov” of the Ministry of Health of the Russian Federation (Sechenov University), Chief Specialist – Clinical Pharmacologist of the Moscow City Department of Health, Moscow

Zakharov V.V., Doctor of Medical Sciences, Professor of the Department of Nervous System Diseases and Neurosurgery, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow

Koryagina N.A., Doctor of Medical Sciences, Professor of the Department of Outpatient Therapy, Perm State Medical University named after Academician E.A. Wagner, Ministry of Health of the Russian Federation, Vice President of the Association of Therapeutic Physicians of Perm Krai, Chairman of the Perm Regional Branch of the Russian Society of Therapists of the Ministry of Health of Perm Krai, Chief Therapist of the Ministry of Health of Perm Krai, Perm

Mikhin V.P., Doctor of Medical Sciences, Professor, Head of the Department of Internal Medicine No. 2, Federal State Budgetary Educational Institution of Higher Education “Kursk State Medical University” of the Ministry of Health of the Russian Federation, Kursk

Osipova I.V., Doctor of Medical Sciences, Professor, Head of the Department of Faculty Therapy and Occupational Diseases, Altai State Medical University of the Ministry of Health of the Russian Federation, Barnaul

Ostroumova O.D., Doctor of Medical Sciences, Professor, Head of the Department of Therapy and Polymorbid Pathology, Federal State Budgetary Educational Institution of Higher Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Health of the Russian Federation, Moscow

Pozdnyak A.O., Doctor of Medical Sciences, Professor, Head of the Department of Therapy, Geriatrics and General Medical Practice, Kazan State Medical Academy – branch of the Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Kazan

Portnyagina U.S., Candidate of Medical Sciences, Associate Professor of the Department of Internal Medicine and General Practice (Family Medicine) of the Federal State Autonomous Educational Institution of Higher Education "North-Eastern Federal University named after. M.K. Ammosov", chief freelance specialist in therapy and general medical practice of the Ministry of Health of the Republic of Sakha (Yakutia), Yakutsk

Statsenko M.E., Doctor of Medical Sciences, Professor, Head of the Department of Internal Medicine, Volgograd State Medical University of the Ministry of Health of the Russian Federation, Volgograd

Tyrenko V.V., Doctor of Medical Sciences, Professor, Head of the Department and Clinic of Faculty Therapy, Federal State Budgetary Educational Institution of Higher Professional Education "S.M. Kirov Military Medical Academy" of the Ministry of Defense of the Russian Federation, Chief Cardiologist of the Ministry of Defense of the Russian Federation, St. Petersburg

Chesnikova A.I., Doctor of Medical Sciences, Professor, Head of the Department of Internal Medicine No. 1 of the Federal State Budgetary Educational Institution of Higher Education “Rostov State Medical University” of the Ministry of Health of the Russian Federation, Chief Therapy Specialist of the Southern Federal District, Rostov-on-Don

Cognitive disorders in the practice of a primary link: Focus for patients with arterial hypertension

Authors:
O.D. OSTROUMOVA, A.I. KOCHETKOV, N.A. SHATALOVA

Personal: Mexidol® and Mexidol® Fort 250 as part of the sequential therapy for cognitive disorders in comorbide patients with joint pathology against the background of arterial hypertension and coronary heart disease

Authors:
L.N. ELISEEV, S.V. KARTASHOVA

FSBEI in Kuban State Medical University of the Ministry of Health of Russia, Krasnodar

The importance of identifying and diagnosing signs of brain damage to arterial hypertension

Authors:
T.M. OSTROUMOVA, O.D. OSTROUMOVA

International multicenteric randomized double-tied placebo-controlled study of evaluating the effectiveness and safety of sequential therapy of patients with chronic brain ischemia drugs Mexidol® and Mexidol® Forte 250 (study of memo): Subanalysis results in patients with arterial hypertension

V.V. ZAKHAROV1, O.D. OSTROUMOVA1,2, A.I. KOCHETKOV2, M.V. KLEPIKOVA2, A.I. FEDIN3

1Federal State Autonomous Educational Institution of Higher Education “I.M. Sechenov First Moscow State Medical University” of the Russian Ministry of Health (Sechenov University);
2Federal State Budgetary Educational Institution of Higher Professional Education “Russian Medical Academy of Continuous Professional Education” of the Russian Ministry of Health, Moscow;
3Federal State Autonomous Educational Institution of Higher Education “N.I. Pirogov Russian National Research Medical University” of the Russian Ministry of Health, Moscow

Place of publication:
THERAPY No. 1 (63) 2023

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com